UnitedHealth Group Incorporated (UNH) — closed signal from July 12, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on October 10, 2025.
Predicted vs. what happened
What happened
Reached its target in 83 days.
The thesis — published July 12, 2025
The recent drop caused by tariff worries pushed the share price down to a more attractive level. Trading data shows many more buyers stepping in, hinting that the slide may be ending. On July 18 the firm is expected to report profit per share up 13%, driven by its Optum division, and to repeat its full-year goals. If that happens, the price could climb back to its February peak near $365, roughly 20% higher than today. Solid financial and sentiment scores also add balance to a tech-heavy portfolio.
Primary drivers
- July 18 results should confirm Optum is growing quickly while keeping costs down.
- Tariff fears pushed the price lower, and heavier buying now points toward a rebound.
- Strong marks on price trend, investor mood, and company basics create a balanced case.
- Healthcare’s steady nature can offset the wild swings often seen in tech holdings.
How it played out
UNH: target reached in 83 days
Lyra published UNH at $300.18 on July 12, 2025, with expected growth of 20% and a target of $355.56. The thesis pointed to tariff worries pushing the price lower, heavier buying, expected July 18 results from Optum, steady healthcare exposure, and strong marks on trend, mood, and company basics.
Inside the window, UNH reached a peak of $373.71 on October 9, 2025, above the target. It reached the target in 83 days. The signal ended at $352.13 on October 10, still below the peak but near the target area. The thesis played out.
What happened during the window
On July 24, 2025, UnitedHealth said it had begun complying with formal criminal and civil Justice Department requests tied to Medicare practices. On July 29, 2025, the company reported second-quarter revenue of $111.6 billion and adjusted earnings of $4.08 per share, and it set 2025 adjusted earnings guidance at at least $16 per share.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.